budesonide
Changes confirmed
Scheduling decisions for cetirizine, budesonide confirmed despite Guild opposition The Therapeutic Goods Administration’s delegate has confirmed previous interim decisions made by the June 2022 meeting of the Advisory Committee on …
Schedule changes
Antihistamine to be available in supermarkets for younger patients due, in part, to concerns over restricted pharmacy trading hours, while a corticosteroid stays script only The Therapeutic Goods Administration’s scheduling …
Keeping on schedule
No change to Symbicort scheduling, TGA confirms, however an antihistamine will move to Schedule 3 The TGA has confirmed a previous interim decision to reject the downscheduling of the asthma …
Mixed results from scheduling committee
Asthma combination medication to remain a prescription product, but new anti-histamine to be downscheduled, as latest scheduling decisions are released A proposal to downschedule the asthma combination medicine containing budesonide …